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Introduction
Since the first description of a novel, flexible, single-arm 
robotic surgical system (da Vinci SP Surgical system, Model 
SP999; Intuitive Surgical Inc.) was first evaluated clinically 
in 2010 on 19 patients undergoing urological surgery [1]. 
Further technical refinements have been developed in this 
robotic system with recent publications containing a detailed 
description of the current design of the robot and cadaveric 
applications in transoral robotic surgery (TORS) [2, 3]. In 
brief, this next generation system incorporates a stereoscopic 
binocular camera and three 6 mm flexible instruments in a 
cannula of 2.5 cm diameter. The flexible robotic arms allow 
the instruments to be deployed from the oral cavity to the 
nasopharynx, oropharynx, hypopharynx, and larynx. Here, 
we describe the early results of the first ever clinical investi-
gation into the feasibility and safety of this updated flexible 
single-arm robot, da Vinci SP (Intuitive Surgical Inc.), in 
TORS.
Methods
Study design
This was a prospective institutional review board approved, 
innovation, development, exploration, assessment, long-term 
study (IDEAL) phase 1 clinical trial conducted in accord-
ance with the Declaration of Helsinki under the institutional 
review board and local regulatory body approval of The 
Abstract The aim of this study was to describe the early 
results of a phase 1 safety and feasibility clinical trial of the 
first clinical use of a novel robot for transoral robotic surgery 
(TORS)—the da Vinci SP (Intuitive Surgical Inc., Sunny-
vale, CA, USA). Study design of this study is prospective 
clinical trial. The methods used in this study are prospective 
innovation, development, exploration, assessment, and long-
term study phase 1 clinical trial. Early results of six patients 
underwent TORS with the da Vinci SP (Intuitive Surgical 
Inc., Sunnyvale, CA, USA) demonstrate access the naso-
pharynx, oropharynx, larynx, and hypopharynx. There were 
no conversions of the robotic surgical system. There were 
no serious adverse events or adverse events related to the 
use of the robot at 30-day follow-up for all six patients. The 
early results of this safety and feasibility trial of the da Vinci 
SP (Intuitive Surgical Inc., Sunnyvale, CA, USA) clearly 
demonstrate that the device is safe and that it is feasible in 
performing TORS to access the nasopharynx, oropharynx, 
larynx, and hypopharynx.
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Chinese University of Hong Kong. The study was registered 
on http://www.ClinicalTrials.gov (NCT03010813).
Study population
Both benign and malignant lesions of the head and neck 
were included with the first six cases, as shown in Table 1.
Study endpoints
Primary endpoint included conversion rates and periopera-
tive complications within 30 days following surgery. Sec-
ondary endpoints included operative time, blood loss, and 
pain scores as documented with a visual analogue scale.
Statistical analysis
The Fisher’s exact test and Mann–Whitney U test will be 
used to compare categorical, and non-parametric data for 
the trial. A p value <0.05 was considered to be statistically 
significant.
Results
Among the first six enrolled patients, there were no con-
versions to alternative surgical approaches. Figures 1, 2 
show the da Vinci SP (Intuitive Surgical Inc., Sunnyvale, 
CA) being utilized in case 3 to examine the larynx (Sup-
plementary video 1). The procedures underwent are listed 
in Table 1, demonstrating that with the da Vinci SP (Intui-
tive Surgical Inc., Sunnyvale, CA, USA) we could reach the 
nasopharynx, oropharynx, hypopharynx, and larynx utiliz-
ing even just a simple daily Crowe–Davis retractor. The main 
use of time was in obtaining adequate exposure with the 
initial use of the da Vinci SP (Intuitive Surgical Inc., Sun-
nyvale, CA, USA), mean 21.3 min (range 4–43 min). The 
initial time to dock the robot was negligible with a mean of 
3.3 min (range 1–5 min). There were no conversions of the 
robotic surgical system. Mean visual analogue scale pain 
scores preoperatively, at 2 week and 30 day postop, were 
0.16 (range 0–1), 0.67 (range 0–4), and 0.16 (range 0–1). 
There were no serious adverse events or adverse events 
related to the use of the da Vinci SP (Intuitive Surgical Inc., 
Sunnyvale, CA, USA). There were surgical complications in 
two patients unrelated to the robot use. Case number four, 
a patient who had previous radiotherapy and poor dentition 
had a fractured right lower molar that required a dental con-
sultation. Case number five had a 1 cm laceration of the 
tongue from the mouthgag that resolved by itself on follow-
up visits. Ta
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Discussion
The early results of this safety and feasibility trial of the 
da Vinci SP (Intuitive Surgical Inc., Sunnyvale, CA, USA) 
clearly demonstrate that the device is safe and that it is fea-
sible in performing transoral surgery to access the nasophar-
ynx, oropharynx, larynx, and hypopharyngeal region. This 
has been achieved in a predominantly Southern Chinese pop-
ulation despite significantly different, in particular smaller 
cranio-facial measurements as compared to Caucasians [4].
A significant advantage offered by the da Vinci SP (Intui-
tive Surgical Inc., Sunnyvale, CA, USA) is the option to use 
three instruments to perform transoral endoscopic surgery. The 
working space within the instruments and camera is roughly 
the size of a tennis ball. This third arm replaces the need of an 
assistant to provide traction and counter traction and allows 
the surgeon to control these maneuvers to better dissect critical 
neurovascular structures. Other distinct advantages include the 
flexible camera enabled with digital zoom that allows magni-
fication and easier visualization of lesions and the different 
compartments of the pharynx.
There are some limitations to the system; now, with the 
extra arm, there is less working space for an assistant to, in 
particular, aid with suction. However, this can be largely over-
come with a suction catheter placed through the nasal cavity 
into the desired location. Another limitation is the lack of bone 
instrumentation to resect, in particular tumors of the nasophar-
ynx and skull base.
Conclusion
The early results of the use of the novel single-port flexible 
robotic system, the da Vinci SP (Intuitive Surgical Inc., Sun-
nyvale CA, USA) demonstrate that the device is safe and fea-
sible to use for TORS to access the nasopharynx, oropharynx, 
larynx, and hypopharynx.
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